Objective: To evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme that allows administration of seasonal influenza vaccination to eligible patients at pharmacies. Design: We analysed 2013–15 data on vaccination uptake in pharmacies via the Sonar reporting system, and the total vaccination uptake via 2011–15 ImmForm GP reporting system data. We conducted an online survey of London pharmacists who participate in the programme to assess time use data, vaccine choice, investment costs, and opinions about the programme. We conducted an online survey of London GPs to assess vaccine choice of vaccine and opinions about the pharmacy vaccine delivery programme. Setting: All London boroughs. Participants: London-bas...
Background Influenza is a significant cause of morbidity and excess mortality, yet vaccine coverage ...
INTRODUCTION: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced...
Poster presented at the 9th PCNE (Pharmaceutical Care Network Europe) Working Conference. Mechelen (...
Objective: To evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme...
OBJECTIVE: To evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme...
Objectives This study evaluated the uptake of Western Australian (WA) pharmacist vaccination service...
Seasonal influenza is a major cause of excess winter deaths and increased hospital admissions. There...
Background: Real world data supporting the effectiveness of the COVID-19 vaccination strategy in the...
OBJECTIVES: To assess the feasibility of measuring influenza vaccination coverage during 2002-2003 a...
Background: On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Sy...
Objective: The aims of this study were to estimate the effect of pharmacists' vaccinating for influe...
Background: To support timely, annual estimation of influenza vaccine effectiveness (VE), we explore...
Background: In Switzerland, the influenza vaccination is recommended for high-risk groups and people...
Background: The first phase of the Queensland Pharmacist Immunisation Pilot (QPIP) ran between April...
In the United Kingdom, COVID vaccinations were rolled out from December 2020. In July 2021 in South ...
Background Influenza is a significant cause of morbidity and excess mortality, yet vaccine coverage ...
INTRODUCTION: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced...
Poster presented at the 9th PCNE (Pharmaceutical Care Network Europe) Working Conference. Mechelen (...
Objective: To evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme...
OBJECTIVE: To evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme...
Objectives This study evaluated the uptake of Western Australian (WA) pharmacist vaccination service...
Seasonal influenza is a major cause of excess winter deaths and increased hospital admissions. There...
Background: Real world data supporting the effectiveness of the COVID-19 vaccination strategy in the...
OBJECTIVES: To assess the feasibility of measuring influenza vaccination coverage during 2002-2003 a...
Background: On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Sy...
Objective: The aims of this study were to estimate the effect of pharmacists' vaccinating for influe...
Background: To support timely, annual estimation of influenza vaccine effectiveness (VE), we explore...
Background: In Switzerland, the influenza vaccination is recommended for high-risk groups and people...
Background: The first phase of the Queensland Pharmacist Immunisation Pilot (QPIP) ran between April...
In the United Kingdom, COVID vaccinations were rolled out from December 2020. In July 2021 in South ...
Background Influenza is a significant cause of morbidity and excess mortality, yet vaccine coverage ...
INTRODUCTION: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced...
Poster presented at the 9th PCNE (Pharmaceutical Care Network Europe) Working Conference. Mechelen (...